Peng, H., Zhang, J., Zhang, P., Chen, L., Tang, L., Yang, X., . . . Ma, J. (2019). ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma. J Exp Clin Cancer Res.
Citação norma ChicagoPeng, Hao, et al. "ARNTL Hypermethylation Promotes Tumorigenesis and Inhibits Cisplatin Sensitivity By Activating CDK5 Transcription in Nasopharyngeal Carcinoma." J Exp Clin Cancer Res 2019.
Citação norma MLAPeng, Hao, et al. "ARNTL Hypermethylation Promotes Tumorigenesis and Inhibits Cisplatin Sensitivity By Activating CDK5 Transcription in Nasopharyngeal Carcinoma." J Exp Clin Cancer Res 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.